358 related articles for article (PubMed ID: 18470910)
1. Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.
Metellus P; Figarella-Branger D; Guyotat J; Barrie M; Giorgi R; Jouvet A; Chinot O;
Cancer; 2008 Jul; 113(1):175-85. PubMed ID: 18470910
[TBL] [Abstract][Full Text] [Related]
2. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients.
Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D
Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166
[TBL] [Abstract][Full Text] [Related]
3. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290
[TBL] [Abstract][Full Text] [Related]
4. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.
Korshunov A; Golanov A; Sycheva R; Timirgaz V
Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
6. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
7. Both location and age predict survival in ependymoma: a SEER study.
McGuire CS; Sainani KL; Fisher PG
Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
[TBL] [Abstract][Full Text] [Related]
8. Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients.
Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Gouvernet J; Jouvet A; Guyotat J
Brain; 2007 May; 130(Pt 5):1338-49. PubMed ID: 17449478
[TBL] [Abstract][Full Text] [Related]
9. Ependymal tumors in childhood.
Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
[TBL] [Abstract][Full Text] [Related]
10. Treatment results in patients with intracranial ependymomas.
Boström A; Boström J; Hartmann W; Pietsch T; Feuss M; von Lehe M; Simon M
Cent Eur Neurosurg; 2011 Aug; 72(3):127-32. PubMed ID: 21630189
[TBL] [Abstract][Full Text] [Related]
11. Outcome predictors for intracranial ependymoma radiosurgery.
Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
Neurosurgery; 2009 Feb; 64(2):279-87; discussion 287-8. PubMed ID: 19190457
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of the prognosis and treatment of adult brain ependymal tumors.
Reni M; Brandes AA; Vavassori V; Cavallo G; Casagrande F; Vastola F; Magli A; Franzin A; Basso U; Villa E
Cancer; 2004 Mar; 100(6):1221-9. PubMed ID: 15022290
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiation therapy for grade II and III intracranial ependymoma.
Mansur DB; Perry A; Rajaram V; Michalski JM; Park TS; Leonard JR; Luchtman-Jones L; Rich KM; Grigsby PW; Lockett MA; Wahab SH; Simpson JR
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):387-91. PubMed ID: 15667957
[TBL] [Abstract][Full Text] [Related]
15. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.
Luyken C; Blümcke I; Fimmers R; Urbach H; Wiestler OD; Schramm J
Cancer; 2004 Jul; 101(1):146-55. PubMed ID: 15222000
[TBL] [Abstract][Full Text] [Related]
17. Primitive intracranial ependymomas. Salah-Azaîz institute experience.
Ben Ammar CN; Kochbati L; Frikha H; Gargouri W; Benna F; Besbes M; Ben Abdallah M; Ben Attia R; Maalej M
Cancer Radiother; 2004 Apr; 8(2):75-80. PubMed ID: 15063874
[TBL] [Abstract][Full Text] [Related]
18. Natural progression of an unresected supratentorial ependymoma.
Wang HC; Hertzog JH; O'Donnell HD; Walter AW
Pediatr Neurosurg; 2008; 44(1):75-8. PubMed ID: 18097198
[TBL] [Abstract][Full Text] [Related]
19. Recurrence in supratentorial anaplastic ependymoma.
Kumar R; Singhal N; Jaiswal SK; Mahapatra AK
Pediatr Neurosurg; 2007; 43(5):364-8. PubMed ID: 17786000
[TBL] [Abstract][Full Text] [Related]
20. Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.
Kreth FW; Faist M; Grau S; Ostertag CB
Cancer; 2006 Mar; 106(6):1372-81. PubMed ID: 16470609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
